Evidence map›Paper›PMID 20620429›Full record

ArticleProgress in cardiovascular diseases

The Framingham Heart Study's impact on global risk assessment.

Asaf Bitton, Thomas A Gaziano

Abstract readHistorical Article
In one paragraph

Article in Progress in cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. A systematic review of the status and methodological considerations for estimating risk of first ever stroke in the general population.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Pooled it
  2. The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2011
    Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Implementation of post-mortem examinations within a large population-based cohort: results from the Hamburg City Health Study.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Asaf BittonDivision of General Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Thomas A Gaziano

Funding

Cost-effective prevention of cardiovascular disease in developing countriesK01TW007141 · FIC · BRIGHAM AND WOMEN'S HOSPITAL · PI GAZIANO, THOMAS A · 2004 to 2011
$864k
FIC NIH HHS K01 TW007141FIC NIH HHS K01 TW007141-05PHS HHS T32HP10251
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality, responsible for about 30% of deaths worldwide. Globally, 80% of total CVD deaths occur in developing countries. In recent years, age-adjusted CVD death has been cut in half in developed countries. Much of the decline is due to reductions in risk factors that the Framingham Heart Study helped to identify. The Framingham Heart Study also helped to classify those at highest risk by creating multivariate risk scores. As a result, other investigators have created various risk prediction scores for their countries. These scores have been the foundation for guidelines and prevention strategies in developed countries. However, most scores requiring blood tests may be difficult to implement in developing countries where limited resources for screening exist. New studies and risk scores inspired by the Framingham Heart Study need to simplify risk scoring in developing countries so that affordable prevention strategies can be implemented.

Indexed as

Global HealthPopulation SurveillanceAdultAgedCardiovascular DiseasesDeveloping CountriesEpidemiologic Research DesignEvidence-Based MedicineFemaleHistory, 20th CenturyHistory, 21st CenturyHumansInternational CooperationMaleMiddle AgedNational Institutes of Health (U.S.)

Identifiers

PMID20620429
PMCPMC2904478

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.